San Francisco, United States
Kirilys Therapeutics, founded in 2022, is a biotechnology startup based in the United States with a mission encapsulated in its slogan: "Improving the lives of #patients with #cancer through the #development and improvement of #therapeutic #treatments." The company operates in the Biotechnology and Health and Wellness industries, striving to revolutionize cancer treatment through innovative therapeutic developments.
Despite its recent inception, Kirilys Therapeutics has attracted attention within the investment community, having secured a Series A investment on 25 January 2023. The investment was led by Global Brain, indicating confidence in the startup's potential to make a substantial impact in the medical field. Investors should consider Kirilys Therapeutics a promising player with a motivated team dedicated to advancing cancer treatments and potentially improving patient outcomes globally.
